Clinical Trials
OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers
OncoArendi Therapeutics SA announced that it has selected OATDโ02 as its clinical development candidate for cancer immunotherapy. Submission of the Company's second Investigational New...
News
Juniper Pharma Services Brings PSD-1 Spray Dryer Online
Juniper Pharma Services , a subsidiary of Juniper Pharmaceuticals, Inc. , has broadened its manufacturing capabilities bringing on-line its new spray dryer following the...
Packaging & Labelling
Videojet launches new, faster 3640 CO2 laser marking system to meet manufacturersโ speed demands
Manufacturers with high volume and high speed production lines rely on their coding and marking systemโs availability to keep production lines running. ...
News
QuVa Pharma Announces Availability of Sodium Bicarbonate Syringe
Compounded Sodium Bicarbonate PF 8.4% 50mEq per syringe is expected to help alleviate chronic drug shortage impacting the nationโs hospitals. It...
Press Releases
New Single Quadrupole Mass Spectrometer and Specialized Columns Designed to Deliver Reproducible and Robust Separations, Increase Analytical Accuracy
Thermo Fisher Scientific Inc., the world leader in serving science, announced new technologies that are designed to allow analytical chemists to obtain high-resolution separations...
Interviews
How can better delivery systems benefit drug manufacturers?
The market demand for integrated delivery systems which combine an injectable drug, its container and the system used to administer it continues to grow...
Drug Research
Sandoz receives approval in Europe for Rixathonยฎ to treat blood cancers and immunological diseases
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the EC ย has approved Rixathonยฎ (biosimilar rituximab*) for use...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read













